Genzyme Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Genzyme stocks.

Genzyme Stocks Recent News

Date Stock Title
Oct 1 BMRN 3 Reasons Why Growth Investors Shouldn't Overlook BioMarin (BMRN)
Oct 1 BMRN BMRN or MYGN: Which Is the Better Value Stock Right Now?
Oct 1 PTCT PTC Therapeutics brain disorder therapy granted FDA review
Oct 1 ALNY Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?
Oct 1 BMRN Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Oct 1 BMRN Down -22.94% in 4 Weeks, Here's Why You Should You Buy the Dip in BioMarin (BMRN)
Oct 1 PTCT PTC Therapeutics Announces FDA Acceptance for Filing of NDA for Sepiapterin for the Treatment of Pediatric and Adult Phenylketonuria Patients
Oct 1 ALNY Not Holding Alnylam Pharmaceuticals (ALNY) Hurt Fidelity Growth Strategies Fund’s Performance
Oct 1 PTCT 5 FDA decisions to watch in the fourth quarter
Sep 30 BMRN Andreas Halvorsen's Firm Expands Grip in BioMarin Pharmaceutical Inc Holding
Sep 30 BMRN Andreas Halvorsen's Strategic Acquisition in BioMarin Pharmaceutical Inc
Sep 30 BMRN High Growth Tech Stocks To Watch For Future Potential
Sep 29 ALNY Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024
Sep 26 EXAS Exact Sciences, Quanterix extend slide after Medicare rates
Sep 26 PTCT PTC Therapeutics Huntington's disease candidate nabs FDA Fast Track status
Sep 26 ALNY Alnylam to Webcast TTR Investor Day
Sep 26 PTCT FDA Grants Fast Track Designation to PTC518 Huntington's Disease Program
Sep 25 BMRN BioMarin Stands Firm on 2027 Revenue Target Amid Ascendis Competition, Goldman Sachs Analyst Remains Bullish
Genzyme

Sanofi Genzyme is an American biotechnology company based in Cambridge, Massachusetts. Since its acquisition in 2011, Genzyme has been a fully owned subsidiary of Sanofi. In 2010, Genzyme was the world’s third-largest biotechnology company, employing more than 11,000 people around the world. As a subsidiary of Sanofi, Genzyme has a presence in approximately 65 countries, including 17 manufacturing facilities and 9 genetic-testing laboratories. Its products are also sold in 90 countries. In 2007, Genzyme generated $3.8 billion in revenue with more than 25 products on the market. In 2006 and 2007, Genzyme was named one of Fortune Magazine’s “100 Best Companies to Work for”. The company donated $83 million worth of products worldwide; in 2006, it made $11 million in cash donations. In 2005, Genzyme was awarded the National Medal of Technology, the highest level of honor awarded by the president of the United States to America’s leading innovators.

Browse All Tags